Jaimini Desai | Page 2

The S&P 500 (SPY) hit its first rough patch since mid-July. And, we've basically retraced the entire last leg higher. As we laid out in our previous commentaries, the conditions...

The S&P 500 (SPY) rally has taken a breather after hitting the 200 day moving average. It's certainly possible that we have topped and are immediately headed lower, it's possible...

It's uncertain whether the current market advance is the start of a new bull market or a bear market rally. What cannot be debated is that biotech stocks are leading...

Tech stocks are rallying. Within the sector, cybersecurity stocks offer the best combination of growth and value especially as the sector's importance grows everyday. Read on to find out why...

The bear market rally has extended further with a strong showing, following the Fed meeting and even more gains in the after-hours sessions due to strong reports from Apple and...

The market is enjoying a nice bounce off the mid-June lows as the S&P 500 nears the critical 4,000 level. Regardless of what happens in the short term, the market...

The bear market provides an opportunity for investors to buy shares of high-quality companies at attractive valuations. Below are 3 such stocks that investors should consider buying during this market...

Every bear market is followed by a bull market...just like how spring inevitably arrives after every winter. Sure, it's easy to lose sight of this fact in the middle of...

The S&P 500 (SPY) has managed to pull off a fantastic bear market rally and now, we are off the mid-June lows by nearly 10%. In last week's commentary, we...

2022 is a challenging year for the market. After battling surging inflation for the first six months, another threat is emerging with rising recession risk. Biotech stocks could be a...

Autonomous vehicles (AV) are the next major evolutionary step in transportation. However, there are many years before its full adoption. Here are 2 stocks that will benefit from this industry's...

The S&P 500 (SPY) declined more following the June CPI report which showed that inflation was worse than expected at 9.1% vs 8.8%. As a result, the odds of a...

With a hawkish Fed and rising recession risk, there are very few areas for investors to find outperformance. One option is defense & aerospace stocks as these companies' revenues are...

Biotech stocks are outperforming due to attractive valuations and strong catalysts. Amgen (AMGN) is one of the top stocks in the space due to its strong product portfolio, pipeline, and...

"Generals always fight the last war." This quote is often attributed to Winston Churchill, and it certainly rings true with the Federal Reserve. By no means am I a Fed...

Market conditions are changing. Concerns about recession are now more paramount than inflation. A winner of this changing dynamic is healthcare and biotech stocks. In today's article, I want to...

In a not very surprising turn of events, the bear market bounce has failed as we've given up more than half of its gains. I, think it validates our decision...

Inflation may be peaking, while growth is certainly slowing. These conditions are tough for most stocks, but pharmaceuticals are an exception. One of the top companies in the space is...

With the economy slowing and oil prices down by about 20% over the last couple of weeks, odds are increasing that inflation could be turning lower. This could be a...

Biotech stocks are starting to move higher as longer-term rates decline. The sector is very cheap with strong long-term fundamentals. Amgen (AMGN), Biogen (BIIB), and Bio-Techne (TECH) are 3 top...

Rising rates are a headwind for most stocks. However, for a handful, they are leading to an earnings boom,. Here are 3 stocks benefitting from higher rates: Humana (HUM), Everest...

The bear market is creating a challenging environment for investors. One place to find outperformance could be high0-quality, healthcare stocks that are paying a dividend. Therefore, investors should consider dividend-paying...

Chinese stocks are outperforming after 2 years of underperformance. Regulatory crackdowns on tech companies seem to have abated, and the government is expected to pivot to economic concerns in the...

GARP is a strategy to blend the best parts of value and growth investing. It's particularly apt as it will allow investors to identify the top growth stocks trading at...

In last week's commentary, we noted that the S&P 500 (SPY) had been range-bound, but that "it may be prudent to pare back on risk and exposure" due to signs...

Growth stocks have been mired in a brutal bear market. However, a handful of stocks are quite cheap and continue to grow at an impressive rate. 3 such stocks that...

The bear market in growth stocks has been brutal. However, there are many high-quality stocks that have seen their earnings, revenues, and margins continue to expand amid this tough environment...

The S&P 500 (SPY) has had a strong thrust higher from very oversold levels in late May, and we've enjoyed some nice gains. Since then, we've trended sideways in a...

Just like bull markets breed excesses and complacency, bear markets do the same but in a different way. While it's an open question of whether or not the S&P 500...

Internet stocks have been crushed during the bear market. For investors looking to take advantage of the bear market, they can increase their chances of success by looking for companies...